Forkhead box transcription factor O1 inhibits cholesterol 7α-hydroxylase in human hepatocytes and in high fat diet-fed mice

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1791, Issue 10, 2009, Pages 991-996

  Li, Tiangang ^a   Ma, Huiyan ^a   Park, Young Joo ^b   Lee, Yoon Kwang ^a,b   Strom, Stephen ^c   Moore, David D ^b   Chiang, John Y L ^a  

^a Northeastern Ohio Medical University   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Bile acid synthesis; Gene expression; Insulin; Metabolic disease; Nuclear receptor

Indexed keywords

CHOLESTEROL 7ALPHA MONOOXYGENASE; INSULIN; MESSENGER RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHR;

ADENOVIRUS; ANIMAL EXPERIMENT; ARTICLE; BILE ACID SYNTHESIS; CANCER CELL CULTURE; CELL NUCLEUS; CELL STRAIN HEPG2; CONTROLLED STUDY; DOWN REGULATION; DYSLIPIDEMIA; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; INSULIN RESISTANCE; KNOCKOUT GENE; LIPID DIET; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ADENOVIRIDAE; ANIMALS; BILE ACIDS AND SALTS; CELL LINE, TUMOR; CELL NUCLEUS; CHOLESTEROL 7-ALPHA-HYDROXYLASE; DIETARY FATS; DOWN-REGULATION; FEEDING BEHAVIOR; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKDOWN TECHNIQUES; GENE TRANSFER TECHNIQUES; HEPATOCYTES; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; RNA INTERFERENCE; RNA, MESSENGER;

ADENOVIRIDAE; MUS;

EID: 69949101448     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.05.004     Document Type: Article

References (35)

1. Chiang J.Y. Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J. Hepatol. 40 (2004) 539-551
2. Makishima M., Okamoto A.Y., Repa J.J., Tu H., Learned R.M., Luk A., Hull M.V., Lustig K.D., Mangelsdorf D.J., and Shan B. Identification of a nuclear receptor for bile acids. Science 284 (1999) 1362-1365
3. Goodwin B., Jones S.A., Price R.R., Watson M.A., McKee D.D., Moore L.B., Galardi C., Wilson J.G., Lewis M.C., Roth M.E., Maloney P.R., Willson T.M., and Kliewer S.A. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell. 6 (2000) 517-526
4. Inagaki T., Choi M., Moschetta A., Peng L., Cummins C.L., McDonald J.G., Luo G., Jones S.A., Goodwin B., Richardson J.A., Gerard R.D., Repa J.J., Mangelsdorf D.J., and Kliewer S.A. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell. Metab. 2 (2005) 217-225
5. Miyake J.H., Wang S.L., and Davis R.A. Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7alpha-hydroxylase. J. Biol. Chem. 275 (2000) 21805-21808
6. Li T., and Chiang J.Y. A novel role of transforming growth factor beta1 in transcriptional repression of human cholesterol 7alpha-hydroxylase gene. Gastroenterology 133 (2007) 1660-1669
7. Watanabe M., Houten S.M., Wang L., Moschetta A., Mangelsdorf D.J., Heyman R.A., Moore D.D., and Auwerx J. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest. 113 (2004) 1408-1418
8. Cariou B., van Harmelen K., Duran-Sandoval D., van Dijk T.H., Grefhorst A., Abdelkarim M., Caron S., Torpier G., Fruchart J.C., Gonzalez F.J., Kuipers F., and Staels B. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J. Biol. Chem. 281 (2006) 11039-11049
9. Zhang Y., Lee F.Y., Barrera G., Lee H., Vales C., Gonzalez F.J., Willson T.M., and Edwards P.A. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 1006-1011
10. Duran-Sandoval D., Cariou B., Percevault F., Hennuyer N., Grefhorst A., van Dijk T.H., Gonzalez F.J., Fruchart J.C., Kuipers F., and Staels B. The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition. J. Biol. Chem. 280 (2005) 29971-29979
11. Ma K., Saha P.K., Chan L., and Moore D.D. Farnesoid X receptor is essential for normal glucose homeostasis. J. Clin. Invest. 116 (2006) 1102-1109
12. Schmoll D., Walker K.S., Alessi D.R., Grempler R., Burchell A., Guo S., Walther R., and Unterman T.G. Regulation of glucose-6-phosphatase gene expression by protein kinase B alpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity. J. Biol. Chem. 275 (2000) 36324-36333
13. Hall R.K., Yamasaki T., Kucera T., Waltner-Law M., O Brien R., and Granner D.K. Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins. J. Biol. Chem. 275 (2000) 30169-30175
14. Biggs III W.H., Meisenhelder J., Hunter T., Cavenee W.K., and Arden K.C. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7421-7426
15. Guo S., Rena G., Cichy S., He X., Cohen P., and Unterman T. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J. Biol. Chem. 274 (1999) 17184-17192
16. Nakae J., Park B.C., and Accili D. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. J. Biol. Chem. 274 (1999) 15982-15985
17. Nakae J., Kitamura T., Silver D.L., and Accili D. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 108 (2001) 1359-1367
18. Valenti L., Rametta R., Dongiovanni P., Maggioni M., Fracanzani A.L., Zappa M., Lattuada E., Roviaro G., and Fargion S. Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis. Diabetes 57 (2008) 1355-1362
19. Qu S., Altomonte J., Perdomo G., He J., Fan Y., Kamagate A., Meseck M., and Dong H.H. Aberrant FoxO1 function is associated with impaired hepatic metabolism. Endocrinology (2006)
20. Puigserver P., Rhee J., Donovan J., Walkey C.J., Yoon J.C., Oriente F., Kitamura Y., Altomonte J., Dong H., Accili D., and Spiegelman B.M. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423 (2003) 550-555
21. Matsumoto M., Han S., Kitamura T., and Accili D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J. Clin. Invest. 116 (2006) 2464-2472
22. Samuel V.T., Choi C.S., Phillips T.G., Romanelli A.J., Geisler J.G., Bhanot S., McKay R., Monia B., Shutter J.R., Lindberg R.A., Shulman G.I., and Veniant M.M. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes 55 (2006) 2042-2050
23. Matsumoto M., Pocai A., Rossetti L., Depinho R.A., and Accili D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell. Metab. 6 (2007) 208-216
24. Li T., Kong X., Owsley E., Ellis E., Strom S., and Chiang J.Y. Insulin regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c. J. Biol. Chem. 281 (2006) 28745-28754
25. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1957) 497-509
26. Kawamori D., Kaneto H., Nakatani Y., Matsuoka T.A., Matsuhisa M., Hori M., and Yamasaki Y. The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation. J. Biol. Chem. 281 (2006) 1091-1098
27. Housley M.P., Rodgers J.T., Udeshi N.D., Kelly T.J., Shabanowitz J., Hunt D.F., Puigserver P., and Hart G.W. O-GlcNAc regulates FoxO activation in response to glucose. J. Biol. Chem. 283 (2008) 16283-16292
28. Yamagata K., Daitoku H., Takahashi Y., Namiki K., Hisatake K., Kako K., Mukai H., Kasuya Y., and Fukamizu A. Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt. Mol. Cell. 32 (2008) 221-231
29. Prada P.O., Zecchin H.G., Gasparetti A.L., Torsoni M.A., Ueno M., Hirata A.E., Corezola do Amaral M.E., Hoer N.F., Boschero A.C., and Saad M.J. Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Endocrinology 146 (2005) 1576-1587
30. Newberry E.P., Xie Y., Kennedy S.M., Luo J., and Davidson N.O. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Hepatology 44 (2006) 1191-1205
31. Hartvigsen K., Binder C.J., Hansen L.F., Rafia A., Juliano J., Horkko S., Steinberg D., Palinski W., Witztum J.L., and Li A.C. A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 878-885
32. Matsuzawa N., Takamura T., Kurita S., Misu H., Ota T., Ando H., Yokoyama M., Honda M., Zen Y., Nakanuma Y., Miyamoto K., and Kaneko S. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46 (2007) 1392-1403
33. Cheema S.K., Cikaluk D., and Agellon L.B. Dietary fats modulate the regulatory potential of dietary cholesterol on cholesterol 7 alpha-hydroxylase gene expression. J. Lipid. Res. 38 (1997) 315-323
34. Li Y., Hou M.J., Ma J., Tang Z.H., Zhu H.L., and Ling W.H. Dietary fatty acids regulate cholesterol induction of liver CYP7alpha1 expression and bile acid production. Lipids 40 (2005) 455-462
35. Li T., Jahan A., and Chiang J.Y. Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells. Hepatology 43 (2006) 1202-1210